Lake Street Advisors Group LLC Increases Stake in Humana Inc. (NYSE:HUM)

Lake Street Advisors Group LLC boosted its position in Humana Inc. (NYSE:HUM) by 17.1% during the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 1,124 shares of the insurance provider’s stock after acquiring an additional 164 shares during the quarter. Lake Street Advisors Group LLC’s holdings in Humana were worth $391,000 at the end of the most recent quarter.

A number of other institutional investors also recently added to or reduced their stakes in the company. Norges Bank purchased a new stake in shares of Humana during the 4th quarter worth $676,800,000. Sanders Capital LLC acquired a new position in shares of Humana during the 4th quarter worth about $489,300,000. Ontario Teachers Pension Plan Board increased its holdings in shares of Humana by 11,647.2% in the 1st quarter. Ontario Teachers Pension Plan Board now owns 1,059,478 shares of the insurance provider’s stock valued at $367,342,000 after acquiring an additional 1,050,459 shares during the last quarter. Putnam Investments LLC raised its position in shares of Humana by 550.3% during the 4th quarter. Putnam Investments LLC now owns 875,489 shares of the insurance provider’s stock worth $400,808,000 after acquiring an additional 740,858 shares in the last quarter. Finally, Allspring Global Investments Holdings LLC lifted its stake in Humana by 255.4% during the first quarter. Allspring Global Investments Holdings LLC now owns 620,793 shares of the insurance provider’s stock worth $215,241,000 after purchasing an additional 446,124 shares during the last quarter. Hedge funds and other institutional investors own 92.38% of the company’s stock.

Humana Price Performance

Shares of NYSE:HUM traded up $0.43 on Wednesday, reaching $386.30. 860,030 shares of the company were exchanged, compared to its average volume of 1,746,552. The firm has a market cap of $46.55 billion, a price-to-earnings ratio of 24.05, a price-to-earnings-growth ratio of 2.23 and a beta of 0.51. Humana Inc. has a 1-year low of $298.61 and a 1-year high of $530.54. The company has a 50-day moving average of $364.30 and a 200-day moving average of $347.07. The company has a current ratio of 1.67, a quick ratio of 1.67 and a debt-to-equity ratio of 0.77.

Humana (NYSE:HUM) last released its quarterly earnings results on Wednesday, April 24th. The insurance provider reported $7.23 earnings per share for the quarter, topping analysts’ consensus estimates of $6.12 by $1.11. Humana had a return on equity of 17.76% and a net margin of 1.82%. The business had revenue of $29.61 billion for the quarter, compared to analysts’ expectations of $28.52 billion. During the same quarter in the prior year, the firm posted $9.38 EPS. The company’s revenue was up 10.7% compared to the same quarter last year. Equities analysts forecast that Humana Inc. will post 16.27 earnings per share for the current fiscal year.

Analyst Ratings Changes

Several research analysts have recently issued reports on HUM shares. The Goldman Sachs Group lowered their target price on shares of Humana from $450.00 to $385.00 and set a “buy” rating for the company in a report on Wednesday, April 3rd. Baird R W raised Humana to a “hold” rating in a report on Thursday, May 30th. UBS Group reduced their target price on Humana from $334.00 to $326.00 and set a “neutral” rating for the company in a report on Thursday, April 25th. Cantor Fitzgerald restated a “neutral” rating and set a $360.00 price target on shares of Humana in a research note on Tuesday. Finally, Oppenheimer reduced their price objective on Humana from $415.00 to $370.00 and set an “outperform” rating for the company in a research note on Thursday, April 25th. Fourteen research analysts have rated the stock with a hold rating and nine have assigned a buy rating to the stock. According to data from MarketBeat.com, Humana presently has an average rating of “Hold” and a consensus price target of $402.60.

Humana Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.